UROY

Uranium Royalty Corp

Price

$3.26

return (12m)

-33.02%

p/e

12.01

p/bv

1.54

DIVIDEND YIELD

0.00%

UROY price

Uranium Royalty Corp

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment UROY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-18.32%

3 months

-6.33%

1 year

-33.02%

2 years

20.56%

5 years

-38.24%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals UROY

Valuation

P/E

12.01

Sector 8.02

Industry 8.02

P/BV

1.54

Sector 1.65

Industry 1.65

P/Revenue (PSR)

2.59

Sector 1.66

Industry 1.66

EV/EBITDA

4.17

Sector -193,371.46

Industry -193,371.46

EV/EBIT

4.18

Sector -38,355,244.89

Industry -38,355,244.89

P/EBITDA

8.82

Sector 1.36

Industry 1.36

P/EBIT

8.84

Sector 0.07

Industry 0.07

P/Total Assets

1.29

Sector 0.77

Industry 0.77

P/Net Current Assets

1.80

Sector -1.83

Industry -1.83

P/Working Capital

1.76

Sector -5.70

Industry -5.70

EPS

0.28

Sector 0.73

Industry 0.73

BVPS

2.14

Sector 10.02

Industry 10.02

Efficiency

Gross Margin

30.66%

Sector 36.34%

Industry 36.34%

EBITDA Margin

33.99%

Sector 6.85%

Industry 6.85%

EBIT Margin

27.15%

Sector 4.48%

Industry 4.48%

Net Profit Margins

21.54%

Sector 2.56%

Industry 2.56%

Asset Turnover

0.40

Sector 0.11

Industry 0.11

Profitability

ROE

15.23%

Sector 3.07%

Industry 3.07%

ROA

13.64%

Sector -0.43%

Industry -0.43%

ROIC

96.83%

Sector -1.83%

Industry -1.83%

Dividends

Dividend yield

0.00%

Sector 0.52%

Industry 0.52%

Payout

0.00%

Sector 10.22%

Industry 10.22%

Debt

Current Ratio

5.94

Sector 1.45

Industry 1.45

Net Debt / EBITDA

-4.65

Sector -7.06

Industry -7.06

Net Debt / EBIT

-4.66

Sector -55,132,930.11

Industry -55,132,930.11

Net Debt / Equity

-0.81

Sector -0.84

Industry -0.84

Gross Debt / Equity

0.00

Sector -0.57

Industry -0.57

Equity/Assets

0.84

Sector 0.43

Industry 0.43

Liabilities/Assets

0.16

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals UROY

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Uranium Royalty Corp ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$3.26

Fair Value

$3.67

Upside

12.80%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

UROY - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Uranium Royalty Corp

Uranium Royalty Corp

Average Investor10 user rating

4.0 (10 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

14

Employees

Uranium Royalty Corp (United States) is listed on the Nasdaq and has a market capitalization of $482.53 million, with shareholders equity totaling $312.77 million.

The company employs approximately 14 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Uranium Royalty Corp reported $186.60 million in revenue, generating net income of $40.19 million.

Key financial metrics include a P/E ratio of 12.01, a price-to-book (P/B) ratio of 1.54, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker UROY.

Market cap

$482.53 million

Net worth

$312.77 million

$312,770,000.00

Assets

$373.32 million

$373,320,000.00

Total Shares Outstanding

146.00 million

146,000,000

Average Daily Trading Volume

$3.36 million

$3,361,407.60

Sector

Others

Industry

Others

UROY

UROY revenue and profits

Financial Results UROY

DRAG THE FRAME TO SEE MORE DATA

UROY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$402.48 23,79% (12M)

P/E

22.30

2.23%

ROE

16.47%

P/BV

3.52

STLA - Stellantis NV

$4.62 --54,84% (12M)

P/E

-0.52

0.00%

ROE

-35.93%

P/BV

0.19

SHEL - Shell PLC ADR

$104.22 46,37% (12M)

P/E

7.41

2.79%

ROE

22.05%

P/BV

1.54

COR - Cencora Inc.

$341.48 0,92% (12M)

P/E

24.58

0.72%

ROE

96.34%

P/BV

19.92

TTE - TotalEnergies SE ADR

$92.47 61,41% (12M)

P/E

6.57

4.27%

ROE

25.94%

P/BV

1.59

ALIZY - Allianz SE ADR

$49.22 --10,64% (12M)

P/E

13.51

2.77%

ROE

18.73%

P/BV

2.42

NSRGY - Nestle SA ADR

$102.93 11,45% (12M)

P/E

12.10

3.90%

ROE

60.60%

P/BV

7.33

ELV - Elevance Health Inc

$415.05 35,67% (12M)

P/E

17.74

1.65%

ROE

11.52%

P/BV

2.03